Zobrazeno 1 - 10 of 14 pro vyhledávání: '"Michele Vespignani"'
1
Akademický článek
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
Autor: Elena Maino, Anna Maria Scattolin, Piera Viero, Rosaria Sancetta, Anna Pascarella, Michele Vespignani, Renato Bassan
Publikováno v: Mediterranean Journal of Hematology and Infectious Diseases, Vol 7, Iss 1, Pp e2015001-e2015001 (2015)
The introduction of newer cytotoxic monoclonal antibodies and the chimeric antigen receptor-modified T-cells is opening a new age in the management of B-lineage adult acute lymphoblastic leukemia. This therapeutic change must be very positively ackno
Externí odkaz: https://doaj.org/article/be7007a895c04084889b54d2eb8f3276
Zobrazit plný text záznamu
2
Current and future management of Ph/BCR-ABL positive ALL
Autor: Rosaria Sancetta, Elena Maino, Anna Maria Scattolin, Renato Bassan, Piera Viero, Silvia Imbergamo, Michele Vespignani
Publikováno v: Expert Review of Anticancer Therapy. 14:723-740
Following the introduction of targeted therapy with tyrosine kinase inhibitors (TKI) at the beginning of the past decade, the outcome of patients with Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL) has dramatically improved.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1960bd2b38af6a0a877d8ac06a8b5c0
https://doi.org/10.1586/14737140.2014.895669
Zobrazit plný text záznamu
3
Modern Immunotherapy of Adult B-Lineage Acute Lymphoblastic Leukemia with Monoclonal Antibodies and Chimeric Antigen Receptor Modified T Cells
Autor: Piera Viero, Elena Maino, Anna Maria Scattolin, Anna Pascarella, Renato Bassan, Rosaria Sancetta, Michele Vespignani
Publikováno v: Mediterranean Journal of Hematology and Infectious Diseases
Mediterranean Journal of Hematology and Infectious Diseases, Vol 7, Iss 1, Pp e2015001-e2015001 (2015)
The introduction of newer cytotoxic monoclonal antibodies and chimeric antigen receptor modified T cells is opening a new age in the management of B-lineage adult acute lymphoblastic leukemia. This therapeutic change must be very positively acknowled
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d380ecd596b05ef3ccd34609af695094
http://europepmc.org/articles/PMC4283921
Zobrazit plný text záznamu
4
Adult T-Cell Leukemia (ATL): Clinical, Pathological and Virological Findings in Two Cases with Unusual Features
Autor: Alfonsino Visona, Luigi Chieco-Bianchi, Roberto Raimondi, Anita De Rossi, Vincenzo Stracca Pansa, Fabrizio Mammano, Roberto Rinaldi, Annarosa Del Mistro, Michele Vespignani, Daniela Saggioro, Paolo Cadrobbi
Publikováno v: Leukemia & Lymphoma. 6:261-266
We describe two cases of adult T-cell leukemia (ATL) in young adult males. One patient was born in the Seychelles Islands and came to live in Italy at 15 years of age; five years later, he started to experience several episodes of infestation by Stro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::31de51ac90d5ec78ce2cbc5649e5f149
https://doi.org/10.3109/10428199209064904
Zobrazit plný text záznamu
5
Recurrent chromosomal aberrations in peripheral T-cell lymphoma
Autor: Teodoro Chisesi, A. Montaldi, Vincenzo Stracca-Pansa, Michele Vespignani, M. Stella, Paola Celli
Publikováno v: Cancer Genetics and Cytogenetics. 48:39-48
Histological, immunological, and cytogenetic analysis of the same neoplastic tissues have been performed on seven patients with peripheral T-cell lymphomas (PTCL). Clonal chromosomal abnormalities in five cases are reported. The most common chromosom
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc0deca3a5edf931405fdcd85aacc9d3
https://doi.org/10.1016/0165-4608(90)90214-u
Zobrazit plný text záznamu
6
Salvage Therapy for Resistant or Relapsing Acute Lymphoblastic Leukemia (ALL) after Idarubicin-Based Induction
Autor: Renato Bassan, Giorgio Rossi, T Barbui, Roberto Sartori, E. Di Bona, Michele Vespignani, T. Lerede, F. Rodeghiero
Publikováno v: Haematology and Blood Transfusion Hämatologie und Bluttransfusion ISBN: 9783642639494
Idarubicin-based induction programs in acute lymphoblastic leukemia (ALL) account for 75%–85% of complete remission rate. A small amount of patients exhibit primary refractoriness, and about 60% of those achieving a remission eventually relapse. Th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::64da7dcd33ccd1ef6f47184dd608bba8
https://doi.org/10.1007/978-3-642-59358-1_77
Zobrazit plný text záznamu
7
Impact of Interferon at Induction Chemotherapy and Maintenance Treatment for Multiple Myeloma Preliminary results of a multicenter study by the Italian Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG)
Autor: Lucilla Tedeschi, Piero Fabris, Teodoro Chisesi, Mauro Spriano, Vittorio Rizzoli, Giovanni Capnist, Luisa Craviotto, A. Contu, Olmeo N, Michele Vespignani, Eugenio Damasio
Publikováno v: Acta Oncologica. 33:527-529
In 1990 the Italian Non-Hodgkin's Lymphoma Cooperative Study Group (NHLSG) started a multicenter study on the role of interferon (IFN) in multiple myeloma (MM). The schedule of treatment was based on the assumption that melphalan plus prednisone (MP)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7684ad010702fe27354fa270b1322360
https://doi.org/10.3109/02841869409083930
Zobrazit plný text záznamu
8
Possible Prognostic Benefit from ABMT in First Remission Adult Acute Lymphoblastic Leukemia
Autor: Piera Viero, T Barbui, Giorgio Lambertenghi-Deliliers, Giorgio Rossi, T. Lerede, Michele Vespignani, P. Fabris, S. Morandi, Enrico Pogliani, E. Di Bona, Renato Bassan, Alessandro Rambaldi, Gianmarco Corneo, Teodosio Izzi
Publikováno v: Transplantation in Hematology and Oncology ISBN: 9783642640414
We analyzed the long-term results of a phase II trial closed in 1993, including ABMT (autologous bone marrow transplant) with post-graft chemotherapy as consolidation therapy for first remission adult ALL patients. Seventy-nine patients in remission
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7080af821e17f76c4b118680cb7e8592
https://doi.org/10.1007/978-3-642-59592-9_25
Zobrazit plný text záznamu
9
Preliminary Observations on Intravenous Idarubicin (4-Demethoxydaunorubicin) in the Chronic and Accelerated Phase of Chronic Myelogenous Leukemia
Autor: Michele Vespignani, Anna D'Emilio, Enrico Dini, Raffaele Battista, Maria A. Pacciarini
Publikováno v: Tumori Journal. 72:389-393
The study included 13 patients with chronic myelogenous leukemia (8 in the chronic phase with high WBC counts at onset, and 5 in the accelerated phase, poorly responding to conventional drugs for the chronic phase). They were treated with 4-demethoxy
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4875373de6d5f52a9cc704304afbbae
https://doi.org/10.1177/030089168607200408
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje